ALTER.PA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 gruod. 2023 @ 18:08):

Stats
Dzisiejszy wolumen	31 613.00
Średni wolumen	4 071.00
Kapitalizacja rynkowa	17.29M
EPS	€0 ( 2024-04-05 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	42.00
ATR14	€0.0360 (2.86%)

Wolumen Korelacja

Długi: -0.01 (neutral)

Krótki: -0.34 (neutral)

Signal:(32.428) Neutral

Theradiag SA Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Theradiag SA Korelacja - Waluta/Towar

0.79
( moderate )

0.84
( strong )

0.00
( neutral )

0.78
( moderate )

0.00
( neutral )

-0.89
( strong negative )

Theradiag SA Finanse

Annual	2022
Przychody:	€12.20M
Zysk brutto:	€5.47M (44.81 %)
EPS:	€-0.0375

FY	2022
Przychody:	€12.20M
Zysk brutto:	€5.47M (44.81 %)
EPS:	€-0.0375

FY	2021
Przychody:	€11.12M
Zysk brutto:	€4.84M (43.52 %)
EPS:	€-0.00731

FY	2020
Przychody:	€10.41M
Zysk brutto:	€4.91M (47.11 %)
EPS:	€-0.0246

Financial Reports:

No articles found.

Theradiag SA

Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides instrumentation, including Theralis that integrates multiplex FIDIS immunofluorescence and ELISA; Theralis µ, a solution for medium sized laboratories; and FIDIS platform used in laboratory for analysis. In addition, it offers therapeutic drug monitoring services for treatment of chronic inflammatory diseases; and LISA tracker, a tool for monitoring of biotherapies, as well as Elisa and rapid tests for SARS-CoV 2 serology. The company was founded in 1986 and is based in Marne La Vallee, France.